Literature DB >> 9650984

Isolation and characterization of sorbitol-fermenting Shiga toxin (Verocytotoxin)-producing Escherichia coli O157:H- strains in the Czech Republic.

M Bielaszewska1, H Schmidt, M A Karmali, R Khakhria, J Janda, K Bláhová, H Karch.   

Abstract

Two sorbitol-fermenting (SF) Shiga toxin-producing Escherichia coli (STEC) O157:H- strains were isolated from patients with hemolytic-uremic syndrome in the Czech Republic in 1995. Their phenotypic and genotypic characteristics and genomic DNA fingerprints were identical or closely related to those of SF STEC O157:H- strains isolated in Germany in 1988 to 1997. This indicates that the Czech isolates belong to the SF STEC O157 clone which is widespread in Germany. It is the first finding of the clone outside Germany.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9650984      PMCID： PMC105006     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome.

Authors:  M Bitzan; H Karch
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities.

Authors:  N A Strockbine; L R Marques; J W Newland; H W Smith; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

3.  Extended phage-typing scheme for Escherichia coli O157:H7.

Authors:  R Khakhria; D Duck; H Lior
Journal:  Epidemiol Infect       Date:  1990-12       Impact factor: 2.451

4.  A biotyping scheme for Shiga-like (Vero) toxin-producing Escherichia coli O157 and a list of serological cross-reactions between O157 and other gram-negative bacteria.

Authors:  S Aleksić; H Karch; J Bockemühl
Journal:  Zentralbl Bakteriol       Date:  1992-01

5.  Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome.

Authors:  F Gunzer; H Böhm; H Rüssmann; M Bitzan; S Aleksic; H Karch
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

6.  [Hemolytic-uremic syndrome in infants due to verotoxin-producing Escherichia coli].

Authors:  H Karch; R Wiss; H Gloning; P Emmrich; S Aleksić; J Bockemühl
Journal:  Dtsch Med Wochenschr       Date:  1990-03-30       Impact factor: 0.628

7.  Development of verotoxin 2- and verotoxin 2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1.

Authors:  J H Hii; C Gyles; T Morooka; M A Karmali; R Clarke; S De Grandis; J L Brunton
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

8.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

9.  Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome.

Authors:  H Rüssmann; H Schmidt; J Heesemann; A Caprioli; H Karch
Journal:  J Med Microbiol       Date:  1994-05       Impact factor: 2.472

10.  Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H-.

Authors:  H Karch; H Böhm; H Schmidt; F Gunzer; S Aleksic; J Heesemann
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948
View more
  22 in total

1.  Phage types and genotypes of Shiga toxin-Producing Escherichia coli O157 in Finland.

Authors:  M Saari; T Cheasty; K Leino; A Siitonen
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 2.  Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H(-) strains: epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis.

Authors:  H Karch; M Bielaszewska
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

3.  An epidemiological study on Verotoxin-producing Escherichia coli (VTEC) infection among population of northern region of Iran (Mazandaran and Golestan provinces).

Authors:  Mohammad Mehdi Aslani; Saeid Bouzari
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

4.  Importance of testing stool specimens for Shiga toxins.

Authors:  C H Park; H J Kim; D L Hixon
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

5.  Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157: indications for an animal reservoir.

Authors:  D Orth; K Grif; M P Dierich; R Würzner
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

6.  The Escherichia coli O157 flagellar regulatory gene flhC and not the flagellin gene fliC impacts colonization of cattle.

Authors:  Heather S Dobbin; Carolyn J Hovde; Christopher J Williams; Scott A Minnich
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 7.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Recycling of Shiga toxin 2 genes in sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM.

Authors:  Alexander Mellmann; Shan Lu; Helge Karch; Jian-guo Xu; Dag Harmsen; M Alexander Schmidt; Martina Bielaszewska
Journal:  Appl Environ Microbiol       Date:  2007-11-02       Impact factor: 4.792

9.  Pathogenic potential of emergent sorbitol-fermenting Escherichia coli O157:NM.

Authors:  Tracy Rosser; Tracy Dransfield; Lesley Allison; Mary Hanson; Nicola Holden; Judith Evans; Stuart Naylor; Roberto La Ragione; J Christopher Low; David L Gally
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

10.  Bacteriophage 2851 is a prototype phage for dissemination of the Shiga toxin variant gene 2c in Escherichia coli O157:H7.

Authors:  Eckhard Strauch; Jens Andre Hammerl; Antje Konietzny; Susanne Schneiker-Bekel; Walter Arnold; Alexander Goesmann; Alfred Pühler; Lothar Beutin
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.